Modafinil: preclinical, clinical, and post-marketing surveillance--a review of abuse liability issues

Ann Clin Psychiatry. 2004 Apr-Jun;16(2):101-9. doi: 10.1080/10401230490453743.

Abstract

Modafinil is an agent that is frequently used in the treatment of narcolepsy. More recently it has been used in the treatment of a variety of psychiatric, neurological, and medical illnesses. Due to its ability to improve wakefulness, modafinil has been viewed as a stimulant. Based on the potential for modafinil to become widely used in a variety of syndromes and settings, evidence from preclinical in vitro and in vivo studies, human laboratory studies, and post-marketing experiences examining the potential abuse liability of modafinil were reviewed. Initial evidence suggests that modafinil has limited potential for large-scale abuse.

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Benzhydryl Compounds / adverse effects*
  • Benzhydryl Compounds / pharmacology
  • Benzhydryl Compounds / therapeutic use*
  • Central Nervous System Stimulants / adverse effects*
  • Central Nervous System Stimulants / pharmacology
  • Central Nervous System Stimulants / therapeutic use*
  • Humans
  • Modafinil
  • Narcolepsy / drug therapy*
  • Product Surveillance, Postmarketing*
  • Substance-Related Disorders*

Substances

  • Benzhydryl Compounds
  • Central Nervous System Stimulants
  • Modafinil